Espada, Haifa A.

HRN: 24-60-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/26/2024
AMPICILLIN 500MG (VIAL)
02/26/2024
03/04/2024
IV
500 Mg
Q 6 Hours
PCAP-C
Waiting Final Action 
02/27/2024
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
02/27/2024
03/04/2024
PO
0.65ml
BID
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: